Viewing Study NCT01526434


Ignite Creation Date: 2025-12-25 @ 2:38 AM
Ignite Modification Date: 2025-12-31 @ 9:45 PM
Study NCT ID: NCT01526434
Status: COMPLETED
Last Update Posted: 2014-03-19
First Post: 2012-02-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Health-related Quality of Life and Patient-reported Outcomes in Rheumatoid Arthritis Patients Treated With Certolizumab Pegol
Sponsor: UCB Pharma SA
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module